Full Truck Alliance Co. Ltd. Announces Second Quarter 2024 Unaudited Financial Results

GUIYANG,China,Aug. 21,2024-- Full Truck Alliance Co. Ltd. ("FTA" or the"Company") (NYSE: YMM),a leading digital freight platform,today announced its unaudited financial results for

08-27

UTime Limited Announces Ambitious AI Health Strategy and Strategic Collaboration

SHENZHEN,China,Aug. 21,2024-- UTime Limited (NASDAQ: WTO) ("UTime" or the "Company") is pleased to announce its ambitious strategy for advancing AI-driven health solutions. Recogni

08-27

China's First Approved KRAS G12C Inhibitor: Innovent Announces the Approval of Dupert® (Fulzerasib) by the National Medical Products Administration of China

SAN FRANCISCOand SUZHOU,China,Aug. 22,2024-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high qua

08-27

Unlock the Power of Direct Investment: How BAI Capital's Direct Approach Transforms the EB-5 Experience

HO CHI MINH CITY,Vietnam,Aug. 22,2024-- BAI Capital,a distinguished boutique real estate developer based in Miami,Florida,is expanding its footprint into Vietnam,significantly impacting the EB-5 marke

08-27

Zepp Health Corporation Reports Second Quarter 2024 Unaudited Financial Results

MILPITAS,Calif.,Aug. 22,2024-- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today reported revenues of US$40.6million;a basic and diluted net lossper share of US$

08-27

Cloud Music Inc. Reports First Half 2024 Financial Results

HANGZHOU,China,Aug. 22,2024-- Cloud Music Inc. (HKEX: 9899,"NetEase Cloud Music" or the "Company"),a leading interactive music streaming service provider in China,today announced i

08-27

LYB to Acquire APK AG Recycling Technology

Expands Company\'s Technology Portfolio and Circular Hub Acquisition increasesLYB Circular and Low Carbon Solutions Business and diversification of innovative recycling technologies

08-27

YolTech Therapeutics Administers First Patient Dose in IIT of YOLT-203, the World's First In Vivo Gene Editing Therapy for PH1

SHANGHAI,Aug. 22,2024--YolTech Therapeutics,a pioneering clinical-stage gene editing company dedicated to delivering lifelong cures,today announced a major milestone: the first patient has been dosed

08-27

Zhihu Inc. Reports Unaudited Second Quarter 2024 Financial Results

BEIJING,Aug. 23,2024-- Zhihu Inc. ("Zhihu" or the "Company") (NYSE: ZH; HKEX: 2390),a leading online content community in China,today announced its unaudited financial results for

08-27

Corina Intrauterine Drug-Eluting System approved in China as a novel treatment for patients with moderate-to-severe intrauterine adhesions (IUA)

The World\'s First-in-Class Intrauterine Drug-Eluting System SHANGHAI,Aug. 23,2024-- Corina Intrauterine Drug-Eluting System("Corina"), developed by Yipurun (Shanghai) Biotechnology Co.,Ltd

08-27